FAM
SGMO

Fred Alger Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Fred Alger Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-30,000
Closed -$251K – 584
2019
Q4 		$251K Buy
+30,000
New +$276K ﹤0.01% 406
2019
Q1 		– Sell
-50,000
Closed -$574K – 556
2018
Q4 		$574K Sell
50,000
-1,000
-2% -$12.4K ﹤0.01% 346
2018
Q3 		$864K Buy
51,000
+11,000
+28% +$167K ﹤0.01% 332
2018
Q2 		$568K Buy
40,000
+7,000
+21% +$116K ﹤0.01% 353
2018
Q1 		$627K Buy
33,000
+24,000
+267% +$513K ﹤0.01% 362
2017
Q4 		$148K Buy
+9,000
New +$134K ﹤0.01% 406

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fred Alger Management's SGMO Position: Q1 2020 in Review

Fred Alger Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2020, closing a stake of 30,000 shares — an estimated $251K sold.

Fred Alger Management first reported a position in SGMO in Q4 2017 and held it in 6 quarters. The position peaked at $864K in Q3 2018. 190 funds tracked by Wall St. Rank hold SGMO as of Q1 2020.

  • Fred Alger Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2020 after selling out during the quarter.
  • Fred Alger Management sold 30,000 SANGAMO THERAPEUTICS INC shares in Q1 2020, an estimated $251K.
  • Fred Alger Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2017 and held it in 6 quarters.
  • Fred Alger Management's SANGAMO THERAPEUTICS INC position peaked at $864K in Q3 2018.
  • 190 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2020.

Based on Fred Alger Management's 13F filing for Q1 2020, filed 15 May 2020.